|
| 35194740 | Trends in Health Service Utilization After Enrollment in an Interdisciplinary Primary Care Clinic for Veterans with Addiction, Social Determinants of Health, or Other Vulnerabilities. | J Gen Intern Med | 2023 |
| 35862898 | Perioperative Management of Extended-release Buprenorphine. | J Addict Med | 2023 |
| 37934544 | Kratom Use Among Pregnant and Lactating Individuals With Substance Use Disorder. | J Addict Med | 2023 |
| 37579107 | Clinician Perspectives on Delivering Medication Treatment for Opioid Use Disorder during the COVID-19 Pandemic: A Qualitative Evaluation. | J Addict Med | 2023 |
| 37579097 | Examining the Primary Care Experience of Patients With Opioid Use Disorder: A Qualitative Study. | J Addict Med | 2023 |
| 37563672 | Costs of implementing a multi-site facilitation intervention to increase access to medication treatment for opioid use disorder. | Implement Sci Commun | 2023 |
| 37790176 | Co-occurring implementation strategies: The effects of academic detailing for opioid use disorder campaign on the advancing pharmacological treatments for opioid use disorder (ADaPT-OUD) study. | Implement Res Pract | 2023 |
| 37551941 | Urine drug testing in the context of opioid analgesic prescribing for chronic pain: a content analysis of U.S. state laws in 2022. | Pain Med | 2023 |
| 37413960 | Urine drug testing among Medicaid enrollees initiating buprenorphine treatment for opioid use disorder within 9 MODRN states. | Drug Alcohol Depend | 2023 |
| 37158468 | Polydrug use among patients on methadone medication treatment: Evidence from urine drug testing to inform patient safety. | Addiction | 2023 |
| 37091535 | Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model. | Implement Res Pract | 2023 |
| 36905310 | Comparative effectiveness of psychosocial interventions in adults with harmful use of alcohol: a systematic review and network meta-analysis. | Addiction | 2023 |
| 37278310 | National Trends in Buprenorphine Treatment for Opioid Use Disorder From 2007 to 2018. | Subst Abus | 2023 |
| 37401501 | Exploring the Association of State Policies and the Trajectories of Buprenorphine Prescriber Patient Caseloads. | Subst Abus | 2023 |
| 37139320 | Prospective acceptability of digital phenotyping among pregnant and parenting people with opioid use disorder: A multisite qualitative study. | Front Psychiatry | 2023 |
| 37327009 | Trends in Use of Medication to Treat Opioid Use Disorder During the COVID-19 Pandemic in 10 State Medicaid Programs. | JAMA Health Forum | 2023 |
| 37196572 | Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration. | Drug Alcohol Depend | 2023 |
| 36810631 | Quality of Depression Care for Veterans Affairs Primary Care Patients with Experiences of Homelessness. | J Gen Intern Med | 2023 |
| 36474004 | Buprenorphine Treatment Episodes During the First Year of COVID: a Retrospective Examination of Treatment Initiation and Retention. | J Gen Intern Med | 2023 |
| 36471194 | Increasing Access to Buprenorphine for Opioid Use Disorder in Primary Care: an Assessment of Provider Incentives. | J Gen Intern Med | 2023 |
| 36469994 | Cessation of self-reported opioid use and impacts on co-occurring health conditions. | Drug Alcohol Depend | 2023 |
| 37234355 | Insights for Conducting Large-Scale Surveys with Veterans Who Have Experienced Homelessness. | J Soc Distress Homeless | 2023 |
| 37234015 | Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment. | JAMA Health Forum | 2023 |
| 36731986 | Potential health benefits of integrated screening strategies for alcohol, tobacco, other substance use, depression, anxiety, and chronic pain among people living with HIV in the USA: a mathematical modelling study. | Lancet HIV | 2023 |
| 37226908 | Patients' Perceptions of Physical Therapists Addressing Opioid Misuse. | Subst Abus | 2023 |
| 37226906 | Examining Systems, Substance Use, and Disenfranchisement: Overview and Proceedings of the 2022 AMERSA Conference. | Subst Abus | 2023 |
| 37226910 | "I'm Clean and Sober, But Not Necessarily Free": Perceptions of Buprenorphine Among Patients in Long-Term Treatment. | Subst Abus | 2023 |
| 37226900 | Perioperative Management of Extended-Release Buprenorphine: A Narrative Review and Case Series. | Subst Abus | 2023 |
| 37037986 | What Contributes to Sustainability? Examining Access to Medications for Opioid Use Disorder in Low-Adopting VHA Facilities. | J Gen Intern Med | 2023 |
| 36724766 | Prior authorization restrictions on medications for opioid use disorder: trends in state laws from 2005 to 2019. | Ann Med | 2023 |
| 37543217 | Medications for opioid use disorder in rural primary care practices: Patient and provider experiences. | J Subst Use Addict Treat | 2023 |
| 36844693 | Cluster analysis to identify patient profiles and substance use patterns among pregnant persons with opioid use disorder. | Addict Behav Rep | 2023 |
| 35194740 | Trends in Health Service Utilization After Enrollment in an Interdisciplinary Primary Care Clinic for Veterans with Addiction, Social Determinants of Health, or Other Vulnerabilities. | J Gen Intern Med | 2023 |
| 37551941 | Urine drug testing in the context of opioid analgesic prescribing for chronic pain: a content analysis of U.S. state laws in 2022. | Pain Med | 2023 |
| 37790176 | Co-occurring implementation strategies: The effects of academic detailing for opioid use disorder campaign on the advancing pharmacological treatments for opioid use disorder (ADaPT-OUD) study. | Implement Res Pract | 2023 |
| 37579107 | Clinician Perspectives on Delivering Medication Treatment for Opioid Use Disorder during the COVID-19 Pandemic: A Qualitative Evaluation. | J Addict Med | 2023 |
| 37579097 | Examining the Primary Care Experience of Patients With Opioid Use Disorder: A Qualitative Study. | J Addict Med | 2023 |
| 37543217 | Medications for opioid use disorder in rural primary care practices: Patient and provider experiences. | J Subst Use Addict Treat | 2023 |
| 37934544 | Kratom Use Among Pregnant and Lactating Individuals With Substance Use Disorder. | J Addict Med | 2023 |
| 37563672 | Costs of implementing a multi-site facilitation intervention to increase access to medication treatment for opioid use disorder. | Implement Sci Commun | 2023 |
| 35862898 | Perioperative Management of Extended-release Buprenorphine. | J Addict Med | 2023 |
| 37158468 | Polydrug use among patients on methadone medication treatment: Evidence from urine drug testing to inform patient safety. | Addiction | 2023 |
| 37413960 | Urine drug testing among Medicaid enrollees initiating buprenorphine treatment for opioid use disorder within 9 MODRN states. | Drug Alcohol Depend | 2023 |
| 37278310 | National Trends in Buprenorphine Treatment for Opioid Use Disorder From 2007 to 2018. | Subst Abus | 2023 |
| 37037986 | What Contributes to Sustainability? Examining Access to Medications for Opioid Use Disorder in Low-Adopting VHA Facilities. | J Gen Intern Med | 2023 |
| 37139320 | Prospective acceptability of digital phenotyping among pregnant and parenting people with opioid use disorder: A multisite qualitative study. | Front Psychiatry | 2023 |
| 37401501 | Exploring the Association of State Policies and the Trajectories of Buprenorphine Prescriber Patient Caseloads. | Subst Abus | 2023 |
| 37234355 | Insights for Conducting Large-Scale Surveys with Veterans Who Have Experienced Homelessness. | J Soc Distress Homeless | 2023 |
| 37234015 | Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment. | JAMA Health Forum | 2023 |
| 37226908 | Patients' Perceptions of Physical Therapists Addressing Opioid Misuse. | Subst Abus | 2023 |